Enclosed Board Meeting outcome for board meeting dated 24.04.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved several items including the appointment of Mr. Nitesh Singh as a Non-Executive Independent Director for a 5-year term, subject to shareholder approval. The board cancelled a previous resolution to increase authorized share capital from INR 75 Crore to INR 125 Crore, effectively withdrawing that capital expansion plan. The company also altered its objects clause to add AI-based healthcare solutions, predictive health analytics, telemedicine, and digital health platforms as new business areas. Additionally, the board cancelled a planned issue of convertible warrants on a preferential basis, and approved a postal ballot notice with Purva Sharegistry appointed as the e-voting agency.
Shareholders will vote on the new director appointment and the expansion into AI/digital healthcare via postal ballot. The cancellation of the authorized capital hike and the preferential warrant issue signals a pullback from the earlier fundraising/expansion plans, while the new objects clause opens a new growth vertical in health-tech.